newsfilter
← Latest News
GlobeNewswire·

Rein Therapeutics Announces Publication of Landmark LTI-03 Clinical Data in Nature Communications

Data support ongoing Phase 2 "RENEW" trialFirst-in-human clinical study produced measurable reductions in multiple markers of lung scarring and inflammation in IPF patientsStudy confirms LTI-03 was safe and